| Cancer Center |
The Eppley Institute was established in 1960 as part of the University of Nebraska Medical Center College of Medicine with funds from the Eugene C. Eppley Foundation, the National Institutes of Health, and the University of Nebraska. In 1983, the National Cancer Institute (NCI) awarded the Institute a Cancer Center Support Grant that has been continually funded since then. In 1999, Dr. Kenneth H. Cowan was named director of the Eppley Institute for Research in Cancer and Allied Diseases and of the UNMC Eppley Cancer Center. Shortly thereafter, the Center was designated an NCI Clinical Cancer Center. Since then, the Cancer Center has conducted almost 400 clinical trials for leukemia and lymphoma, as well as breast, prostate, pancreatic, gastrointestinal and lung cancers. The UNMC Eppley Cancer Center is renowned for its basic research programs in chemical carcinogenesis, molecular, cellular, and structural biology and translational research in new therapies. Research programs focus on cancer genes and molecular regulation, molecular and biochemical etiology, experimental therapeutics and disease-oriented working groups.
|